Efficacy of upadacitinib vs dupilumab for moderate-to-severe atopic dermatitis: analysis of time spent in itch response state from the Heads Up study

被引：0
|
作者：
Blauvelt, Andrew [1 ]
de Bruin-Weller, Marjolein [2 ]
Kwatra, Shawn G. [3 ]
Gooderham, Melinda J. [4 ]
Kim, Brian [5 ,6 ,7 ,8 ]
Liu, Yingyi [9 ]
Chu, Alvina D. [9 ]
Ofori, Sarah [9 ]
Platt, Andrew [9 ]
Calimlim, Brian M. [9 ]
Silverberg, Jonathan, I [10 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR USA
[2] Univ Med Ctr Utrecht, Dept Dermatol & Allergol, Utrecht, Netherlands
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[4] Queens Univ, Kingston, ON, Canada
[5] Icahn Sch Med Mt Sinai, Kimberly & Eric J Waldman Dept Dermatol, New York, NY USA
[6] Icahn Sch Med Mt Sinai, Mark Lebwohl Ctr Neuroinflammat & Sensat, New York, NY USA
[7] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY USA
[8] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY USA
[9] AbbVie Inc, N Chicago, IL USA
[10] George Washington Univ, Sch Med & Hlth Sci, Dept Dermatol, Washington, DC USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 190卷
关键词：
upadacitinib; dupilumab; atopic dermatitis; moderate-to-severe; pruritus;
D O I：
10.1093/bjd/ljad498.031
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
526
引用
收藏
页码：II28 / II29
页数：2
相关论文
共 50 条
  • [31] Real-life efficacy and safety of upadacitinib in adolescents with moderate-to-severe atopic dermatitis unresponsive to dupilumab: A case series
    Patruno, Cataldo
    Fabbrocini, Gabriella
    Potestio, Luca
    Genco, Lucia
    Napolitano, Maddalena
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (07) : E901 - E903
  • [32] Rapid skin clearance and itch improvement with upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: results from a phase 3b head-to-head clinical trial (Heads Up)
    Simpson, Eric L.
    Costanzo, Antonio
    Prajapati, Vimal H.
    Calimlim, Brian M.
    Chu, Alvina D.
    Wu, Tianshuang
    Eyerich, Kilian
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II30 - II31
  • [33] Dupilumab treatment induces rapid clinical improvement of itch in patients with moderate-to-severe atopic dermatitis
    Silverberg, Jonathan I.
    Eckert, Laurent
    Ardeleanu, Marius
    Chen, Zhen
    Akinlade, Bolanle
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozi, Gianluca
    Gadkari, Abhijit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB113 - AB113
  • [34] Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
    Mareschal, Adrien
    Puzenat, Eve
    Aubin, Francois
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 (01)
  • [35] A study into the drug dupilumab in Japanese adults with moderate-to-severe atopic dermatitis
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (01) : E4 - E4
  • [36] Comparison of Efficacy of Baricitinib and Dupilumab in the Treatment of Chinese Moderate-To-Severe Atopic Dermatitis: A Retrospective Study
    Liu, Bo
    Song, Xiaoting
    Liao, Shuanglu
    Luan, Tingting
    Zhao, Zuotao
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (10) : 966 - 974
  • [37] Switching from dupilumab to abrocitinib in patients with moderate-to-severe atopic dermatitis: an analysis of responders and nonresponders to dupilumab
    Silverberg, Jonathan, I
    Simpson, Eric L.
    Thyssen, Jacob P.
    Pink, Andrew E.
    Weidinger, Stephan
    Chan, Gary
    Lazariciu, Irina
    Clibborn, Claire
    Guler, Erman
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [38] Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
    Ferrucci, Silvia
    Casazza, Giovanni
    Zussino, Martina
    Tavecchio, Simona
    Marzano, Angelo V.
    Tedeschi, Micol
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [39] The efficacy and immunological effects of upadacitinib in the treatment of moderate-to-severe Chinese atopic dermatitis patients
    Li, Lu
    Wu, Naming
    Liu, Tingyu
    Yu, Guoqun
    Wang, Yifei
    He, Ting
    Mao, Raymond
    Yang, Liu
    Li, Yan
    Shen, Chen
    Tao, Juan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [40] Efficacy and safety of upadacitinib for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis
    Huang, Yuanjie
    Cai, Limin
    Wu, Xuerui
    Chen, Chen
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 725 - 733
12345